Considering the amount of lawsuits this has caused, will a higher price for SNTS resolve this? Any reference to similar situations in the past? Comments?
Sentiment: Strong Buy
worked for Wyeth labs when they announced to acquire warner lambert and gain rights to Lipitor. Pfizer wanted Lipitor and filed suit under the same rationale...board hadn't acted in shareholder best interest. warner lambert ended up going to Pfizer for a higher price
Would love to now what the Board of Directors was thinking making such a low offer and there response to all of the lawsuits. For me December 21 can't come soon enough to lock this in as LT Cap Gains and get out of this stock. I have been looking at Biomarin which I think is a litlle like Santarus - if it anyone wants to check them out the symbol is BMRN.